Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
Using a frozen section technique, we have assessed the effects of N-methyl-D-aspartate (NMDA) antagonist upon brain swelling caused by ischemic brain edema in a rat model of focal cerebral infarction. Although pretreatment with the competitive NMDA antagonist, D-CPPene or the noncompetitive NMDA antagonist, CNS 1102 reduced both the volumes of infarction and ischemic edema in the cerebral hemisphere, mean reduction in brain edema was proportionately similar to decrease in infarct volume in the same animals (correlation coefficient, r = 0.82, p < 0.001). There was, therefore, no evidence of disproportionately greater effects with NMDA antagonist upon brain edema.
Park
C K
CK
Department of Neurosurgery, Catholic University Medical College, Seoul, Korea.
McCulloch
J
J
Jung
D S
DS
Kang
J K
JK
Choi
C R
CR
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000473:pathology; D001929:Brain Edema / Q000473:pathology*; D002544:Cerebral Infarction / Q000473:pathology*; D005110:Extracellular Space / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology*; D008297:Male; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D006146:Guanidines; D010879:Piperazines; C065286:SDZ EAA 494; C079779:aptiganel; D016202:N-Methylaspartate